Scholars Central

Mini reviewPublished 27 Feb 2021

Emerging Medicines in Multiple Sclerosis

Authors: Kommu Santhosh

Department of Biotechnology, Kakatiya University, Warangal, Telangana, India

Journal of Neuroinfectious Diseases

Volume 12 · Issue 2 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Multiple sclerosis (MS) is a progressive autoimmune neurological condition that mostly affects young adults and may be debilitating. Multiple sclerosis (MS) is currently treated with a number of disease-modifying medications (DMDs) (MS). There has been a surge in the discovery and advancement of possible novel drugs for MS, including oral therapies, in recent years. The aim of this review is to provide concise information on the mechanism of action, signs, symptoms, diagnosis as well as new therapies and medications that may be used off-label in MS.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Neuroinfectious Diseases.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Neuroinfectious Diseases
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Kommu Santhosh”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels